Crossmark

Biological Evaluation and Antitumor Activity of Dolutegravir Derivatives Containing a 1,2,3-Triazole Linker

Published Online: 2025-10-31

Published Print: 2025-09

Authors

Sun, Bin

Hou, Xixi

Liu, Xiaofei

Deng, Peng
License Information

Text and Data Mining valid from 2025-09-01

Version of Record valid from 2025-09-01
More Information

Article History

Received: 8 February 2025

Revised: 19 February 2025

Accepted: 21 February 2025

First Online: 31 October 2025

CONFLICT OF INTEREST

: The authors declare that they have no conflicts of interest.

Document is current